Association of prostate cancer and benign prostate hyperplasia with polymorphisms in VDR gene, CYP17 gene and SRD5A2 gene among Lebanese men.

被引：1
|
作者：
Kuddus, Ruhul H. [1 ]
El Ezzi, Asmahan A. [1 ]
El-saidi, Mohammed A. [1 ]
机构：
[1] Utah Valley, Orem, UT USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5304
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of Benign Prostate Hyperplasia with Polymorphisms in VDR, CYP17, and SRD5A2 Genes among Lebanese Men
    El Ezzi, Asmahan Ali
    Zaidan, Wissam Rateeb
    El-Saidi, Mohammed Ahmed
    Al-Ahmadieh, Nabil
    Mortenson, Jeffrey Benjamin
    Kuddus, Ruhul Haque
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1255 - 1262
  • [2] The association of 5α-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population
    Onen, Ilke Hacer
    Ekmekci, Abdullah
    Eroglu, Muzaffer
    Polat, Fazli
    Biri, Hasan
    [J]. DNA AND CELL BIOLOGY, 2007, 26 (02) : 100 - 107
  • [3] CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
    M T Tayeb
    C Clark
    N E Haites
    L Sharp
    G I Murray
    H L McLeod
    [J]. British Journal of Cancer, 2003, 88 : 928 - 932
  • [4] CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
    Tayeb, MT
    Clark, C
    Haites, NE
    Sharp, L
    Murray, GI
    McLeods, HL
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (06) : 928 - 932
  • [5] Associations between polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JK
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 374 - 374
  • [6] CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population
    Sobti, R. C.
    Onsory, Khadijeh
    Al-Badran, Adnan Issa
    Kaur, Pushpinder
    Watanabe, Masatoshi
    Krishan, A.
    Mohan, Harsh
    [J]. DNA AND CELL BIOLOGY, 2006, 25 (05) : 287 - 294
  • [7] Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of benign prostatic hyperplasia: a case-control study in northern Chinese population
    Zhang, Lin-Lin
    Song, Yu
    He, Ling-Ling
    Chen, Guo-Qiang
    Fu, Ji-Cheng
    Liu, Lei
    Xi, Bao
    Wang, Lei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8660 - 8676
  • [8] Polymorphism of the SRD5A2 gene and the risk of prostate cancer
    Dusenka, Robert
    Tomaskin, Roman
    Kliment, Jan
    Dobrota, Dusan
    Dusenkova, Svetlana
    Vilckova, Marta
    Sivonova, Monika Kmet'ova
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 10 (06) : 3151 - 3156
  • [9] SRD5A2 gene polymorphisms and the risk of prostate cancer:: A meta-analysis
    Ntais, C
    Polycarpou, A
    Ioannidis, JPA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (07) : 618 - 624
  • [10] Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JKV
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (04) : 246 - 253
12345